Follow
Asım OREM, MD, Prof.
Asım OREM, MD, Prof.
Karadeniz Tecnical University, Medical Faculty, Medical Biochemistry
Verified email at ktu.edu.tr
Title
Cited by
Cited by
Year
Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant–antioxidant system in patients with psoriasis
BV Kural, A Örem, G Çimşit, YE Yandı, M Calapoǧlu
Clinica chimica acta 328 (1-2), 71-82, 2003
2462003
Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight‐obese individuals …
A González‐Sarrías, R García‐Villalba, M Romo‐Vaquero, C Alasalvar, ...
Molecular nutrition & food research 61 (5), 1600830, 2017
2372017
Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients
BV Kural, A Örem, G Çimşit, HA Uydu, YE Yandi, A Alver
Clinica Chimica Acta 332 (1-2), 23-30, 2003
1772003
The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between …
MV Selma, A González-Sarrías, J Salas-Salvadó, C Andrés-Lacueva, ...
Clinical Nutrition 37 (3), 897-905, 2018
1612018
Hazelnut-enriched diet improves cardiovascular risk biomarkers beyond a lipid-lowering effect in hypercholesterolemic subjects
A Orem, FB Yucesan, C Orem, B Akcan, BV Kural, C Alasalvar, F Shahidi
Journal of clinical lipidology 7 (2), 123-131, 2013
1262013
Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes
F Mujgan Sonmez, E Demir, A Orem, S Yildirmis, F Orhan, A Aslan, ...
Journal of child neurology 21 (1), 70-74, 2006
1132006
Decreased nitric oxide production in patients with Behçet’s disease
A Örem, B Vanizor, G Cimşit, E Kıran, O Değer, M Malkoç
Dermatology 198 (1), 33-36, 1999
1101999
Prognostic value of red cell distribution width in patients with pulmonary embolism
S Ozsu, Y Abul, S Gunaydin, A Orem, T Ozlu
Clinical and Applied Thrombosis/Hemostasis 20 (4), 365-370, 2014
1082014
How does colistin-induced nephropathy develop and can it be treated?
G Ozkan, S Ulusoy, A Orem, M Alkanat, S Mungan, E Yulug, FB Yucesan
Antimicrobial agents and chemotherapy 57 (8), 3463-3469, 2013
1072013
Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing–remitting multiple sclerosis treated with interferon beta
C Boz, M Ozmenoglu, S Velioglu, K Kilinc, A Orem, Z Alioglu, ...
Clinical neurology and neurosurgery 108 (2), 124-128, 2006
1062006
The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant–antioxidant system in patients with dyslipidemia
BV Kural, C Örem, HA Uydu, A Alver, A Örem
Coronary Artery Disease 15 (5), 277-283, 2004
912004
The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels …
A Örem, YE Yandi, B Vanizor, G Çimşit, HA Uydu, M Malkoç
Clinical Biochemistry 35 (3), 217-224, 2002
862002
Protective effect of the grape seed proanthocyanidin extract in a rat model of contrast-induced nephropathy
G Ozkan, S Ulusoy, A Orem, S Ersoz, M Alkanat, FB Yucesan, K Kaynar, ...
Kidney and Blood Pressure Research 35 (6), 445-453, 2013
712013
Relationship between lipid peroxidation and disease activity in patients with Behçet's disease
A Örem, H Efe, O Deǧer, G Çimşit, HA Uydu, B Vanizor
Journal of dermatological science 16 (1), 11-16, 1997
701997
Hazelnut consumption decreases the susceptibility of LDL to oxidation, plasma oxidized LDL level and increases the ratio of large/small LDL in normolipidemic healthy subjects …
FB Yücesan, A Örem, BV Kural, C Örem, İ Turan
The Anatolian Journal of Cardiology 10 (1), 28, 2010
682010
Prevalence of metabolic syndrome in patients with mucosal lichen planus: a case–control study
L Baykal, DA Arıca, S Yaylı, A Örem, S Bahadır, E Altun, H Yaman
American journal of clinical dermatology 16, 439-445, 2015
622015
Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications
B Vanizor, A Örem, SC Karahan, E Kiran, C Erem, R Aliyazicioğlu, ...
Diabetes research and clinical practice 54 (1), 33-39, 2001
622001
Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects.
C Erem, O Değer, M Bostan, A Orem, M Sönmez, S Ulusoy, M Telatar
Acta cardiologica 54 (2), 77-81, 1999
621999
Lp (a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçet's disease.
A Orem, O Değer, O Memiş, S Bahadir, E Ovali, G Cimşit
Annals of the rheumatic diseases 54 (9), 726-729, 1995
611995
Effect of antiepileptic drugs on plasma lipoprotein (a) and other lipid levels in childhood
F Müjgan Aynaci, F Orhan, A Orem, S Yildirmis, Y Gedik
Journal of child neurology 16 (5), 367-369, 2001
602001
The system can't perform the operation now. Try again later.
Articles 1–20